{"mainPropery":{"diseaseId":73,"diseaseName":"Immunodeficiency with hyper IgM type 1","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/73/immunodeficiency-with-hyper-igm-type-1","synonyms":["X-linked hyper IgM syndrome","Hyper IgM immunodeficiency, x-linked","Hyper IgM syndrome","Hyper IgM syndrome 1","XHIM","HIGM","IHIS","HIGM1"],"synonyms-with-source":[{"name":"X-linked hyper IgM syndrome"},{"name":"Hyper IgM immunodeficiency, x-linked"},{"name":"Hyper IgM syndrome"},{"name":"Hyper IgM syndrome 1"},{"name":"XHIM"},{"name":"HIGM"},{"name":"IHIS"},{"name":"HIGM1"}],"identifiers":[{"identifierType":"OMIM","identifierId":"308230"},{"identifierType":"OMIM","identifierId":"605258"},{"identifierType":"OMIM","identifierId":"606843"},{"identifierType":"OMIM","identifierId":"608106"},{"identifierType":"OMIM","identifierId":"608184"},{"identifierType":"ORPHANET","identifierId":"101088"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":13,"diseaseTypeName":"Immune System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":151,"resourceName":"Jeffrey Modell Foundation","abbreviation":"JMF","address1":"780 Third Ave","address2":"","address3":"","address4":"","address5":"","city":"New York","state":"NY","zip":"10017","country":"United States","phone":"","tty":"","tollFree":"","fax":"212-764-4180","email":"info@jmfworld.org","url":"http://www.info4pi.org/","freeText":"JMF is a global patient organization devoted to early and precise diagnosis, meaningful treatments, and ultimately, cures - through clinical and basic research, physician education, patient support, advocacy, public awareness and newborn screening."},{"resourceID":152,"resourceName":"International Patient Organization for Primary Immunodeficiencies","abbreviation":"IPOPI","address1":"Rock Bottom, Trerieve","address2":"Downderry","address3":"PL11 3LY","address4":"","address5":"","city":"","state":"","zip":"","country":"United Kingdom","phone":"44-01503-250-668/961","tty":"","tollFree":"","fax":"","email":"Info@ipopi.org","url":"https://ipopi.org","freeText":""},{"resourceID":161,"resourceName":"Immune Deficiency Foundation","abbreviation":"","address1":"110 West Road, Suite 300","address2":"","address3":"","address4":"","address5":"","city":"Towson","state":"MD","zip":"21204","country":"United States","phone":"","tty":"","tollFree":"1-800-296-4433","fax":"+1-410-321-9165","email":"https://www.primaryimmune.org/services/ask-idf/","url":"https://www.primaryimmune.org/","freeText":""},{"resourceID":875,"resourceName":"Immune Deficiencies Foundation Australia","abbreviation":"","address1":"PO Box 969","address2":"Penrith NSW 2751","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"Australia","phone":"800-100-198","tty":"","tollFree":"","fax":"","email":"info@idfa.org.au","url":"http://www.idfa.org.au/"},{"resourceID":4018,"resourceName":"Primary Immune Deficiency UK","abbreviation":"PID UK","address1":"PO Box 6970","address2":"","address3":"","address4":"","address5":"","city":"Basingstoke","state":"","zip":"RG24 4XL","country":"United Kingdom","phone":"","tty":"","tollFree":"0800 987 8986","fax":"","email":"hello@piduk.org","url":"http://www.piduk.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"Online Mendelian Inheritance in Man (OMIM) is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n<a href='http://www.omim.org/308230' target='_blank'>The Online Mendelian Inheritance in Man (OMIM)</a><br /><a href='http://www.omim.org/605258' target='_blank'>The Online Mendelian Inheritance in Man (OMIM)</a><br /><a href='http://www.omim.org/606843' target='_blank'>The Online Mendelian Inheritance in Man (OMIM)</a><br /><a href='http://www.omim.org/608106' target='_blank'>The Online Mendelian Inheritance in Man (OMIM)</a><br /><a href='http://www.omim.org/608184' target='_blank'>The Online Mendelian Inheritance in Man (OMIM)</a><br />","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=DetailsSearch&Term=(hyper%5BTitle%5D+AND+IgM%5BTitle%5D+AND+syndrome%5BTitle%5D)+AND+(hasabstract%5Btext%5D+AND+%222003%2F04%2F18%22%5BPDat%5D+%3A+%222008%2F04%2F15%22%5BPDat%5D)' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Immunodeficiency with hyper IgM type 1. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://www.clinicaltrials.gov/ct2/results?cond=%22Immunodeficiency+with+hyper+IgM+type+1%22' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Immunodeficiency with hyper IgM type 1. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/x-linked-hyper-igm-syndrome' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Immunodeficiency with hyper IgM type 1. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C0398689' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=101088' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=xlhi' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1700,"resourceId":2173,"resourceName":"Merck Manual","descriptionText":"The&nbsp;<a href='http://www.merckmanuals.com/professional/immunology-allergic-disorders/immunodeficiency-disorders/hyper-igm-syndrome' target='_blank'>Merck Manual</a> for health care professionals provides information on&nbsp;Immunodeficiency with hyper IgM type 1.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:308230' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2722,"resourceId":4053,"resourceName":"Patient Registry","descriptionText":"A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with Immunodeficiency with hyper IgM type 1. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries</a>.<br />\r\n<br />\r\nRegistries for&nbsp;Immunodeficiency with hyper IgM type 1:<br />\r\n<a href='https://usidnet.org/about-the-registry/patient-participation/' target='_blank'>United States Immunodeficiency Network (USIDENT) Registry</a><br />&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":534,"questionText":"What is hyper IgM syndrome?","answerText":"<strong>Hyper IgM syndrome</strong> is a type of primary immunodeficiency syndrome. Primary immunodeficiency occurs when part of a person’s immune system is missing or does not work correctly. The bodies of people with primary immunodeficiency can’t get rid of germs or protect themselves from new germs as well as they should. Primary immunodeficiencies are inherited, meaning they are passed down from parents to children.[365] \r\n<p>Hyper IgM syndromes are characterized by normal or elevated serum <a href=\"http://ghr.nlm.nih.gov/glossary=immunoglobulin\" target=_blank>immunoglobulin</a> M levels with absence of immunoglobulin G, A, and E. Immunoglobulins are proteins found in the blood. Hyper IgM results in a susceptibility to bacterial infections and sometimes opportunistic infections. There are five different types of hyper IgM syndromes (types 1-5). The types are distinguished by the location of the <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002371.htm\" target=_blank>gene</a> mutation involved.[366]</p>","dateModified":"2013-08-01T16:26:00"},"basicQuestions":[{"questionId":539,"questionText":"What are the symptoms of hyper IgM syndrome?","answerText":"Symptoms and physical findings associated with hyper IgM syndrome usually become apparent in the first or second year of life.[368][369] This condition may be characterized by recurrent pus-producing (pyogenic) bacterial infections of the upper and lower respiratory tract including the sinuses (sinusitis) and/or the lungs (pneumonitis or pneumonia); the middle ear (otitis media); the membrane that lines the eyelids and the white portions (sclera) of the eyes (conjunctivitis); the skin (pyoderma); and/or, in some cases, other areas.[367][368][369]<br><br>Other signs of the disease include enlarged tonsils, liver, and spleen, chronic diarrhea, and an increased risk of unusual or “opportunistic” infections&nbsp;and non-Hodgkins lymphoma.[367][368][369] Opportunistic infections are infections caused by microorganisms that usually do not cause disease in individuals with fully functioning immune systems (non-immunocompromised) or widespread (systemic) overwhelming disease by microorganisms that typically cause only localized, mild infections. In individuals with Hyper-IgM Syndrome, such opportunistic infections may include those caused by Pneumocystis carinii, a microorganism that causes a form of pneumonia, or Cryptosporidium, a single-celled parasite (protozoa) that can cause infections of the intestinal tract.[369]<br><br>In addition, individuals with Hyper-IgM Syndrome are prone to certain autoimmune disorders affecting particular elements of the blood. Autoimmune attacks on red blood cells lead to anemia, while autoimmune destruction of infection-fighting neutrophils further increases the risk of infection.[367][369]<br><br>The range and severity of symptoms and physical features associated with this disorder may vary from case to case.[369]","dateModified":"2013-08-01T12:44:00","resourceClassificationName":"Symptoms","references":[{"referenceId":365,"authors":"","articleTitle":"Primary Immunodeficiency","bookWebsiteJournalTitle":"National Institute of Child Health and Human Development (NICHD)","date":"April 7, 2008","volume":"","pages":"","url":"http://www.nichd.nih.gov/publications/pubs/pages/primary_immuno.aspx#WhatisPrimaryImmunodeficiency","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":367,"authors":"","articleTitle":"Primary Immunodeficiency Diseases: Some Examples","bookWebsiteJournalTitle":"National Institute of Child Health and Human Development (NICHD)","date":"April 7, 2008","url":"http://www.nichd.nih.gov/publications/pubs/pages/primary_immuno.aspx","dateAccessed":"2008-04-16T00:00:00"},{"referenceId":368,"authors":"","articleTitle":"Hyper IgM Immunodeficiency","bookWebsiteJournalTitle":"Primary Immunodeficiency Resource Center","date":"2008","url":"http://www.info4pi.org/aboutPI/index.cfm?section=aboutPI&content=syndromes&area=13&CFID=4740438&CFTOKEN=e428d93702237370-4B49B0F6-0023-0F1A-C289B29F1FE43C9A","dateAccessed":"2008-04-16T00:00:00"},{"referenceId":369,"authors":"","articleTitle":"Hyper IgM Syndrome","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"2002","url":"http://www.rarediseases.org/search/rdbdetail_abstract.html?disname=Hyper%20IgM%20Syndrome","dateAccessed":"2008-04-16T00:00:00"}]},{"questionId":540,"questionText":"What causes hyper IgM syndrome?","answerText":"A flawed <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002371.htm\" target=_blank>gene</a> (or genes) in T-cells (a type of white blood cell that is part of the immune system and helps the body fight diseases or harmful substances) is responsible for hyper IgM syndrome. The faulty T-cells do not give B-cells a signal they need to switch from making IgM to IgA and IgG. Most cases (approximately 70%) of hyper-IgM syndrome are linked to a <a href=\"http://www.genome.gov/glossary.cfm?key=recessive\" target=_blank>recessive mutation</a> on the <a href=\"http://ghr.nlm.nih.gov/chromosome/X\" target=_blank>X chromosome</a>. These cases are inherited as an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002051.htm\" target=_blank>X-linked recessive genetic trait</a>. Because males do not have a second, healthy, X-chromosome to offset the disease, boys far out number girls with this disease.[367][368][369] <br><br>A small number of cases of hyper IgM syndrome have been attributed to <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=_blank>autosomal recessive</a> and <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=_blank>autosomal dominant</a> genetic inheritance. In addition, a rare acquired form of the disorder has been described in the medical literature.[369] ","dateModified":"2013-08-01T12:47:00","resourceClassificationName":"Cause","references":[{"referenceId":367,"authors":"","articleTitle":"Primary Immunodeficiency Diseases: Some Examples","bookWebsiteJournalTitle":"National Institute of Child Health and Human Development (NICHD)","date":"April 7, 2008","url":"http://www.nichd.nih.gov/publications/pubs/pages/primary_immuno.aspx","dateAccessed":"2008-04-16T00:00:00"},{"referenceId":368,"authors":"","articleTitle":"Hyper IgM Immunodeficiency","bookWebsiteJournalTitle":"Primary Immunodeficiency Resource Center","date":"2008","url":"http://www.info4pi.org/aboutPI/index.cfm?section=aboutPI&content=syndromes&area=13&CFID=4740438&CFTOKEN=e428d93702237370-4B49B0F6-0023-0F1A-C289B29F1FE43C9A","dateAccessed":"2008-04-16T00:00:00"},{"referenceId":369,"authors":"","articleTitle":"Hyper IgM Syndrome","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"2002","url":"http://www.rarediseases.org/search/rdbdetail_abstract.html?disname=Hyper%20IgM%20Syndrome","dateAccessed":"2008-04-16T00:00:00"}]},{"questionId":541,"questionText":"How might hyper IgM syndrome be treated?","answerText":"The cornerstone of treatment for individuals with hyper IgM syndrome is regular injections of intravenous immunogloblulin (IVIG). This treatment not only supplies missing IgG antibodies, but also prompts a drop in IgM antibodies.[367][368] Patients with neutropenia can take <a href=\"http://jama.ama-assn.org/cgi/reprint/295/9/1088.pdf\" target=_blank>granulocyte colony-stimulating factor</a> (G-CSF). Antibiotics may also be prescribed to prevent the respiratory infection, pneumocystis carinii pneumonia.[368]<br><br>Most children with hyper-IgM syndrome respond well to treatment, become symptom-free and resume normal growth.[367]","dateModified":"2013-08-01T16:25:00","resourceClassificationName":"Treatment","references":[{"referenceId":367,"authors":"","articleTitle":"Primary Immunodeficiency Diseases: Some Examples","bookWebsiteJournalTitle":"National Institute of Child Health and Human Development (NICHD)","date":"April 7, 2008","url":"http://www.nichd.nih.gov/publications/pubs/pages/primary_immuno.aspx","dateAccessed":"2008-04-16T00:00:00"},{"referenceId":368,"authors":"","articleTitle":"Hyper IgM Immunodeficiency","bookWebsiteJournalTitle":"Primary Immunodeficiency Resource Center","date":"2008","url":"http://www.info4pi.org/aboutPI/index.cfm?section=aboutPI&content=syndromes&area=13&CFID=4740438&CFTOKEN=e428d93702237370-4B49B0F6-0023-0F1A-C289B29F1FE43C9A","dateAccessed":"2008-04-16T00:00:00"}]}],"references":[{"referenceId":10302,"authors":"Diane Hollenbaugh, Lynne H. Wi, Hans D. Ochs, Shigeaki Nonoyama, Laura S. Grosmaire, Jeffrey A. Ledbetter, Randolf J. Noelle, Harry Hill, Alejandro Aruffo","articleTitle":"The random inactivation of the X chromosome carrying the defective gene responsible for X-linked hyper IgM syndrome (X-HIM) in female carriers of HIGM1","bookWebsiteJournalTitle":"Journal of Clinical Investigation","date":"August 1994","volume":"94(2)","pages":"612-622","url":"http://www.ncbi.nlm.nih.gov/pubmed/7518839","dateAccessed":"2015-12-17T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10301,"authors":"Thomas J. Kipps","articleTitle":"X inactivation and immunocompetence in female carriers of the X-linked hyper-IgM syndrome","bookWebsiteJournalTitle":"Journal of Clinical Investigation","date":"August 1994","volume":"94(2)","pages":"469","url":"http://www.ncbi.nlm.nih.gov/pubmed/8040297","dateAccessed":"2015-12-17T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10303,"authors":"Genevieve de Saint Basile, Marie-Dominique Tabone, Anne Durandy, Florence Phan, Alain Fischer, Francoise Le Deist","articleTitle":"CD40 ligand expression deficiency in a female carrier of the X-linked hyper-IgM syndrome as a result of X chromosome lyonization","bookWebsiteJournalTitle":"European Journal of Immunology","date":"January 1999","volume":"29(1)","pages":"367-377","url":"http://www.ncbi.nlm.nih.gov/pubmed/9933119","dateAccessed":"2015-12-17T00:00:00","authors2":"","placeOfPublication":"","publisher":""}],"relatedDiseases":[],"gardCases":[{"caseId":54328,"abbreviatedInquiry":"Can female carriers of Immunodeficiency with hyper IgM type 1 have symptoms? ","caseQuestions":[{"questionId":9894,"questionText":"Can female carriers of immunodeficiency with hyper IgM type 1 have immunodeficiency symptoms?&nbsp;","answerText":"While female carriers of immunodeficiency with hyper IgM type 1 typically do not report &nbsp; symptoms, we have identified several studies that explore the possibility of female carriers exhibiting symptoms.[10301][10302]<br />\r\n<br />\r\nWe additionally identified one case report described in the medical literature that you might find helpful. Case reports document clinical findings associated with individual cases. It is important to keep in mind that the clinical findings documented in these case reports are based on specific individuals and may differ from one affected person to another. This particular case report describes a female carrier of immunodeficiency with hyper IgM type 1 with symptoms of an immunodeficiency including: recurrent infections of the lower and upper respiratory tract and low <a href=\"http://ghr.nlm.nih.gov/glossary=immunoglobulin\" target=\"_blank\">IgG</a> and<a href=\"http://ghr.nlm.nih.gov/glossary=immunoglobulin\" target=\"_blank\"> IgA</a> serum (blood) levels.[10303] <br />\r\n<br />","dateModified":"2015-12-30T11:03:00","references":[{"referenceId":10301,"authors":"Thomas J. Kipps","articleTitle":"X inactivation and immunocompetence in female carriers of the X-linked hyper-IgM syndrome","bookWebsiteJournalTitle":"Journal of Clinical Investigation","date":"August 1994","volume":"94(2)","pages":"469","url":"http://www.ncbi.nlm.nih.gov/pubmed/8040297","dateAccessed":"2015-12-17T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10302,"authors":"Diane Hollenbaugh, Lynne H. Wi, Hans D. Ochs, Shigeaki Nonoyama, Laura S. Grosmaire, Jeffrey A. Ledbetter, Randolf J. Noelle, Harry Hill, Alejandro Aruffo","articleTitle":"The random inactivation of the X chromosome carrying the defective gene responsible for X-linked hyper IgM syndrome (X-HIM) in female carriers of HIGM1","bookWebsiteJournalTitle":"Journal of Clinical Investigation","date":"August 1994","volume":"94(2)","pages":"612-622","url":"http://www.ncbi.nlm.nih.gov/pubmed/7518839","dateAccessed":"2015-12-17T00:00:00","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":10303,"authors":"Genevieve de Saint Basile, Marie-Dominique Tabone, Anne Durandy, Florence Phan, Alain Fischer, Francoise Le Deist","articleTitle":"CD40 ligand expression deficiency in a female carrier of the X-linked hyper-IgM syndrome as a result of X chromosome lyonization","bookWebsiteJournalTitle":"European Journal of Immunology","date":"January 1999","volume":"29(1)","pages":"367-377","url":"http://www.ncbi.nlm.nih.gov/pubmed/9933119","dateAccessed":"2015-12-17T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]}]},{"caseId":21461,"abbreviatedInquiry":"My son was recently diagnosed with hyper IgM syndrome. What information can you provide about this condition?","caseQuestions":[{"questionId":533,"questionText":"What is the immune system?","answerText":"The immune system is the body's first line of defense against germs. The immune system uses specialized cells and organs to help the body recognize and respond to foreign invaders. It even has its own circulatory system, called the lymphatic system.[364]","dateModified":"2013-08-01T12:36:00","references":[{"referenceId":364,"authors":"","articleTitle":"Immune System and Disorders","bookWebsiteJournalTitle":"MedlinePlus","date":"April 15, 2008","url":"http://www.nlm.nih.gov/medlineplus/immunesystemanddisorders.html","dateAccessed":"2008-04-16T00:00:00"}]},{"questionId":534,"questionText":"What is hyper IgM syndrome?","answerText":"<strong>Hyper IgM syndrome</strong> is a type of primary immunodeficiency syndrome. Primary immunodeficiency occurs when part of a person’s immune system is missing or does not work correctly. The bodies of people with primary immunodeficiency can’t get rid of germs or protect themselves from new germs as well as they should. Primary immunodeficiencies are inherited, meaning they are passed down from parents to children.[365] \r\n<p>Hyper IgM syndromes are characterized by normal or elevated serum <a href=\"http://ghr.nlm.nih.gov/glossary=immunoglobulin\" target=_blank>immunoglobulin</a> M levels with absence of immunoglobulin G, A, and E. Immunoglobulins are proteins found in the blood. Hyper IgM results in a susceptibility to bacterial infections and sometimes opportunistic infections. There are five different types of hyper IgM syndromes (types 1-5). The types are distinguished by the location of the <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002371.htm\" target=_blank>gene</a> mutation involved.[366]</p>","dateModified":"2013-08-01T16:26:00","references":[{"referenceId":365,"authors":"","articleTitle":"Primary Immunodeficiency","bookWebsiteJournalTitle":"National Institute of Child Health and Human Development (NICHD)","date":"April 7, 2008","volume":"","pages":"","url":"http://www.nichd.nih.gov/publications/pubs/pages/primary_immuno.aspx#WhatisPrimaryImmunodeficiency","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":366,"authors":"","articleTitle":"Hyper IgM Immunodeficiency Syndrome","bookWebsiteJournalTitle":"MeSH","date":"","url":"http://www.nlm.nih.gov/cgi/mesh/2008/MB_cgi?mode=&index=24001&field=all&HM=&II=&PA=&form=&input=","dateAccessed":"2008-04-16T00:00:00"}]},{"questionId":539,"questionText":"What are the symptoms of hyper IgM syndrome?","answerText":"Symptoms and physical findings associated with hyper IgM syndrome usually become apparent in the first or second year of life.[368][369] This condition may be characterized by recurrent pus-producing (pyogenic) bacterial infections of the upper and lower respiratory tract including the sinuses (sinusitis) and/or the lungs (pneumonitis or pneumonia); the middle ear (otitis media); the membrane that lines the eyelids and the white portions (sclera) of the eyes (conjunctivitis); the skin (pyoderma); and/or, in some cases, other areas.[367][368][369]<br><br>Other signs of the disease include enlarged tonsils, liver, and spleen, chronic diarrhea, and an increased risk of unusual or “opportunistic” infections&nbsp;and non-Hodgkins lymphoma.[367][368][369] Opportunistic infections are infections caused by microorganisms that usually do not cause disease in individuals with fully functioning immune systems (non-immunocompromised) or widespread (systemic) overwhelming disease by microorganisms that typically cause only localized, mild infections. In individuals with Hyper-IgM Syndrome, such opportunistic infections may include those caused by Pneumocystis carinii, a microorganism that causes a form of pneumonia, or Cryptosporidium, a single-celled parasite (protozoa) that can cause infections of the intestinal tract.[369]<br><br>In addition, individuals with Hyper-IgM Syndrome are prone to certain autoimmune disorders affecting particular elements of the blood. Autoimmune attacks on red blood cells lead to anemia, while autoimmune destruction of infection-fighting neutrophils further increases the risk of infection.[367][369]<br><br>The range and severity of symptoms and physical features associated with this disorder may vary from case to case.[369]","dateModified":"2013-08-01T12:44:00","resourceClassificationName":"Symptoms","references":[{"referenceId":365,"authors":"","articleTitle":"Primary Immunodeficiency","bookWebsiteJournalTitle":"National Institute of Child Health and Human Development (NICHD)","date":"April 7, 2008","volume":"","pages":"","url":"http://www.nichd.nih.gov/publications/pubs/pages/primary_immuno.aspx#WhatisPrimaryImmunodeficiency","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":367,"authors":"","articleTitle":"Primary Immunodeficiency Diseases: Some Examples","bookWebsiteJournalTitle":"National Institute of Child Health and Human Development (NICHD)","date":"April 7, 2008","url":"http://www.nichd.nih.gov/publications/pubs/pages/primary_immuno.aspx","dateAccessed":"2008-04-16T00:00:00"},{"referenceId":368,"authors":"","articleTitle":"Hyper IgM Immunodeficiency","bookWebsiteJournalTitle":"Primary Immunodeficiency Resource Center","date":"2008","url":"http://www.info4pi.org/aboutPI/index.cfm?section=aboutPI&content=syndromes&area=13&CFID=4740438&CFTOKEN=e428d93702237370-4B49B0F6-0023-0F1A-C289B29F1FE43C9A","dateAccessed":"2008-04-16T00:00:00"},{"referenceId":369,"authors":"","articleTitle":"Hyper IgM Syndrome","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"2002","url":"http://www.rarediseases.org/search/rdbdetail_abstract.html?disname=Hyper%20IgM%20Syndrome","dateAccessed":"2008-04-16T00:00:00"}]},{"questionId":540,"questionText":"What causes hyper IgM syndrome?","answerText":"A flawed <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002371.htm\" target=_blank>gene</a> (or genes) in T-cells (a type of white blood cell that is part of the immune system and helps the body fight diseases or harmful substances) is responsible for hyper IgM syndrome. The faulty T-cells do not give B-cells a signal they need to switch from making IgM to IgA and IgG. Most cases (approximately 70%) of hyper-IgM syndrome are linked to a <a href=\"http://www.genome.gov/glossary.cfm?key=recessive\" target=_blank>recessive mutation</a> on the <a href=\"http://ghr.nlm.nih.gov/chromosome/X\" target=_blank>X chromosome</a>. These cases are inherited as an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002051.htm\" target=_blank>X-linked recessive genetic trait</a>. Because males do not have a second, healthy, X-chromosome to offset the disease, boys far out number girls with this disease.[367][368][369] <br><br>A small number of cases of hyper IgM syndrome have been attributed to <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=_blank>autosomal recessive</a> and <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002049.htm\" target=_blank>autosomal dominant</a> genetic inheritance. In addition, a rare acquired form of the disorder has been described in the medical literature.[369] ","dateModified":"2013-08-01T12:47:00","resourceClassificationName":"Cause","references":[{"referenceId":367,"authors":"","articleTitle":"Primary Immunodeficiency Diseases: Some Examples","bookWebsiteJournalTitle":"National Institute of Child Health and Human Development (NICHD)","date":"April 7, 2008","url":"http://www.nichd.nih.gov/publications/pubs/pages/primary_immuno.aspx","dateAccessed":"2008-04-16T00:00:00"},{"referenceId":368,"authors":"","articleTitle":"Hyper IgM Immunodeficiency","bookWebsiteJournalTitle":"Primary Immunodeficiency Resource Center","date":"2008","url":"http://www.info4pi.org/aboutPI/index.cfm?section=aboutPI&content=syndromes&area=13&CFID=4740438&CFTOKEN=e428d93702237370-4B49B0F6-0023-0F1A-C289B29F1FE43C9A","dateAccessed":"2008-04-16T00:00:00"},{"referenceId":369,"authors":"","articleTitle":"Hyper IgM Syndrome","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"2002","url":"http://www.rarediseases.org/search/rdbdetail_abstract.html?disname=Hyper%20IgM%20Syndrome","dateAccessed":"2008-04-16T00:00:00"}]},{"questionId":541,"questionText":"How might hyper IgM syndrome be treated?","answerText":"The cornerstone of treatment for individuals with hyper IgM syndrome is regular injections of intravenous immunogloblulin (IVIG). This treatment not only supplies missing IgG antibodies, but also prompts a drop in IgM antibodies.[367][368] Patients with neutropenia can take <a href=\"http://jama.ama-assn.org/cgi/reprint/295/9/1088.pdf\" target=_blank>granulocyte colony-stimulating factor</a> (G-CSF). Antibiotics may also be prescribed to prevent the respiratory infection, pneumocystis carinii pneumonia.[368]<br><br>Most children with hyper-IgM syndrome respond well to treatment, become symptom-free and resume normal growth.[367]","dateModified":"2013-08-01T16:25:00","resourceClassificationName":"Treatment","references":[{"referenceId":367,"authors":"","articleTitle":"Primary Immunodeficiency Diseases: Some Examples","bookWebsiteJournalTitle":"National Institute of Child Health and Human Development (NICHD)","date":"April 7, 2008","url":"http://www.nichd.nih.gov/publications/pubs/pages/primary_immuno.aspx","dateAccessed":"2008-04-16T00:00:00"},{"referenceId":368,"authors":"","articleTitle":"Hyper IgM Immunodeficiency","bookWebsiteJournalTitle":"Primary Immunodeficiency Resource Center","date":"2008","url":"http://www.info4pi.org/aboutPI/index.cfm?section=aboutPI&content=syndromes&area=13&CFID=4740438&CFTOKEN=e428d93702237370-4B49B0F6-0023-0F1A-C289B29F1FE43C9A","dateAccessed":"2008-04-16T00:00:00"}]},{"questionId":542,"questionText":"Where can I learn more about hyper IgM syndrome?","answerText":"<p>The National Institute of Child Health and Human Development (NICHD) Clearinghouse. The NICHD provides information on primary immunodeficiency syndromes, including hyper IgM syndrome,&nbsp;and on other topics related to the health of children, adults, and families.<br><a href=\"http://www.nichd.nih.gov/publications/pubs/primary_immuno.cfm#PrimaryImmunoDiseases\" target=_blank>http://www.nichd.nih.gov/publications/pubs/primary_immuno.cfm#PrimaryImmunoDiseases</a></p>\r\n<p>The National Institute of Child Health and Human Development Clearinghouse (NICHD)<br>PO Box 3006<br>Rockville, MD 20847<br>Toll free:&nbsp; 800-370-2943<br>Fax:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 301-984-1473<br>E-mail:&nbsp;&nbsp;&nbsp;&nbsp;<a href=\"mailto:NICHDClearinghouse@mail.nih.gov\">NICHDClearinghouse@mail.nih.gov</a><br>Web site:<a href=\"http://www.nichd.nih.gov/\" target=_blank>http://www.nichd.nih.gov/<br></a><br>In addition, many support organizatons for this condition offer patient friendly information. To view a list of these support organizations, go to the \"<a href=\"http://rarediseases.info.nih.gov/gard/73/immunodeficiency-with-hyper-igm-type-1/resources/5\" target=_blank>Organizations</a>\" tab of this webpage. </p>","dateModified":"2013-08-01T13:14:00","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":5689,"phenoTypeName":"Cirrhosis","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":13401,"phenoTypeName":"Diarrhea","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":4081,"phenoTypeName":"Failure to thrive","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":2701,"phenoTypeName":"Hepatitis","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":8738,"phenoTypeName":"Meningitis","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":15514,"phenoTypeName":"Neutropenia","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":9751,"phenoTypeName":"Oral ulcer","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":10723,"phenoTypeName":"Recurrent lower respiratory tract infections","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":1239,"phenoTypeName":"Sclerosing cholangitis","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":1873,"phenoTypeName":"Sepsis","frequencyText":"Very rare","percentRanges":"1%-4%"},{"phenoTypeId":7940,"phenoTypeName":"Absence of lymph node germinal center","percentRanges":"-"},{"phenoTypeId":15528,"phenoTypeName":"Autoimmune hemolytic anemia","percentRanges":"-"},{"phenoTypeId":13079,"phenoTypeName":"Autoimmune thrombocytopenia","percentRanges":"-"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":13740,"phenoTypeName":"Bronchiectasis","percentRanges":"-"},{"phenoTypeId":1121,"phenoTypeName":"Chronic hepatitis","percentRanges":"-"},{"phenoTypeId":10672,"phenoTypeName":"Decreased circulating IgA level","percentRanges":"-"},{"phenoTypeId":9527,"phenoTypeName":"Decreased circulating IgE","percentRanges":"-"},{"phenoTypeId":3593,"phenoTypeName":"Decreased circulating IgG level","percentRanges":"-"},{"phenoTypeId":8225,"phenoTypeName":"Decreased T cell activation","percentRanges":"-"},{"phenoTypeId":4356,"phenoTypeName":"Dysgammaglobulinemia","percentRanges":"-"},{"phenoTypeId":2336,"phenoTypeName":"Enlarged tonsils","percentRanges":"-"},{"phenoTypeId":9,"phenoTypeName":"Epididymitis","percentRanges":"-"},{"phenoTypeId":9812,"phenoTypeName":"Gingivitis","percentRanges":"-"},{"phenoTypeId":15517,"phenoTypeName":"Hemolytic anemia","percentRanges":"-"},{"phenoTypeId":8115,"phenoTypeName":"Hepatomegaly","percentRanges":"-"},{"phenoTypeId":10673,"phenoTypeName":"Immunodeficiency","percentRanges":"-"},{"phenoTypeId":8850,"phenoTypeName":"Impaired Ig class switch recombination","percentRanges":"-"},{"phenoTypeId":7938,"phenoTypeName":"Impaired memory B cell generation","percentRanges":"-"},{"phenoTypeId":13609,"phenoTypeName":"Increased circulating IgM level","percentRanges":"-"},{"phenoTypeId":13313,"phenoTypeName":"Lymphadenopathy","percentRanges":"-"},{"phenoTypeId":7953,"phenoTypeName":"Myelodysplasia","percentRanges":"-"},{"phenoTypeId":10592,"phenoTypeName":"Osteomyelitis","percentRanges":"-"},{"phenoTypeId":10670,"phenoTypeName":"Recurrent bacterial infections","percentRanges":"-"},{"phenoTypeId":9967,"phenoTypeName":"Recurrent infection of the gastrointestinal tract","percentRanges":"-"},{"phenoTypeId":1116,"phenoTypeName":"Recurrent upper and lower respiratory tract infections","percentRanges":"-"},{"phenoTypeId":7888,"phenoTypeName":"Recurrent upper respiratory tract infections","percentRanges":"-"},{"phenoTypeId":3886,"phenoTypeName":"Splenomegaly","percentRanges":"-"},{"phenoTypeId":8672,"phenoTypeName":"Stomatitis","percentRanges":"-"},{"phenoTypeId":15512,"phenoTypeName":"Thrombocytopenia","percentRanges":"-"},{"phenoTypeId":5707,"phenoTypeName":"X-linked recessive inheritance","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Immunodeficiency_with_hyper_IgM_type_1"}